Response-Adapted Sequential Azacitidine and Induction Chemotherapy in Patients > 60 Years Old with Newly Diagnosed AML Eligible for Chemotherapy (RAS-AZIC): First Data of the Interim Analysis of the DRKS00004519 Study of the East German Study Group (OSHO)
| Autor: | Al-Ali, Haifa Kathrin *, Jaekel, Nadja *, Hubert, Karolin *, Krahl, Rainer *, Haenel, Mathias *, Maschmeyer, Georg, Herbst, Regina *, Jakob, Christian *, Schultze, Susann *, Wang, Song-Yau *, Brosteanu, Oana *, Niederwieser, Dietger |
|---|---|
| Zdroj: | In Blood 3 December 2015 126(23):1346-1346 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|